On Aug. 31, 2026, Scan.com announced $220 million in combined equity and debt financing. The company said the raise followed a doubling of revenue over the past year to an annualized run rate above $165 million. These revenue figures come from the company and are repeated by the trade sites that covered the round.[1],[4]
The equity piece was a $90 million Series C led by Noteus Partners, with Aviva, Concord Health Partners, YZR Capital and Oxford Capital taking part. Debt facilities of $130 million came from VerisFi Capital and Atempo Growth. Medical Device Network says the debt is earmarked for mergers and acquisitions and working capital.[1],[4]
IT Brief UK reports that Scan.com will use the funding to add more imaging providers across the US and to invest in the systems that route patients, schedule scans and return diagnostic results. Digital Health News says the money will also go toward agentic AI infrastructure.[3],[2]
Nathalie Bruls, general partner at Noteus, said in the company's release that the firm led the round because it sees Scan.com as uniquely positioned to power the future of diagnostic imaging. James Olsen, managing partner at Concord Health Partners, said the company's ability to improve access to diagnostic imaging while reducing cost and complexity fits Concord's mission.[1]